Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Aug 18, 2022; 12(8): 231-249
Published online Aug 18, 2022. doi: 10.5500/wjt.v12.i8.231
Published online Aug 18, 2022. doi: 10.5500/wjt.v12.i8.231
Kidney disease in non-kidney solid organ transplantation
Kurtis J Swanson, Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, MN 55414, United States
Author contributions: Swanson KJ contributed to the concept/design, article drafting, critical revision of article and approval of article.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kurtis J Swanson, MD, Assistant Professor, Division of Nephrology and Hypertension, University of Minnesota, 717 Delaware Street SE, Suite 353, MMC 1932, Minneapolis, MN 55414, United States. kjswanson88@gmail.com
Received: January 29, 2022
Peer-review started: January 29, 2022
First decision: March 25, 2022
Revised: April 7, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: August 18, 2022
Processing time: 201 Days and 1.6 Hours
Peer-review started: January 29, 2022
First decision: March 25, 2022
Revised: April 7, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: August 18, 2022
Processing time: 201 Days and 1.6 Hours
Core Tip
Core Tip: Kidney disease in the non-kidney solid organ transplant population occurs at significantly higher rate than the general population. Pre-transplant morbidity as well as peri-/post-transplant events contribute to this prevalence. Management strategies throughout the journey of non-renal solid organ transplantation are being studied, including transplantation after native kidney failure to help offset the morbidity/mortality of chronic kidney disease and maximize the benefit of non-kidney solid organ transplantation.